Chylothorax in a patient with HIV-related Kaposi's sarcoma

Sonia Cherian; Onyeka Maureen Umerah; Muhammad Tufail; Rakesh K Panchal

doi:10.1136/bcr-2018-227641

Chylothorax in a patient with HIV-related Kaposi's sarcoma

BMJ Case Rep. 2019 Jan 22;12(1):e227641. doi: 10.1136/bcr-2018-227641.

Authors

Sonia Cherian^{1

2}, Onyeka Maureen Umerah^{1

2}, Muhammad Tufail^{1

2}, Rakesh K Panchal^{1

2}

Affiliations

¹ Respiratory Medicine, Glenfield Hospital Department of Respiratory Disorders Lung Disorders and Thoracic Medicine, Leicester, UK.
² Respiratory Medicine, Institute for Lung Health, Glenfield Hospital, Leicester, Leicester, UK.

Abstract

We present a case of a 33-year-old man with a background of HIV and Kaposi's sarcoma (KS), who presented with a right sided chylothorax. He was managed with percutaneous chest drainage and talc pleurodesis, in addition to his chemotherapy and antiretroviral therapy for KS and HIV, respectively. Good clinical control of the chylothorax remained 4 months post drainage. This case report summarises the approach to investigating and managing pleural effusion, and in particular chylothorax, in HIV patients.

Keywords: HIV / AIDS; respiratory cancer; ultrasonography.

Publication types

Case Reports

MeSH terms

Adult
Aftercare
Chest Tubes
Chylothorax / diagnostic imaging*
Chylothorax / etiology
Chylothorax / metabolism
Chylothorax / therapy*
Diagnosis, Differential
Diet Therapy / methods
Drainage / methods*
HIV / growth & development
HIV Infections / complications
HIV Infections / virology
Humans
Male
Pleural Effusion / diagnostic imaging
Pleural Effusion / etiology
Pleural Effusion / metabolism
Pleural Effusion / therapy
Pleurodesis / methods*
Radiography, Thoracic
Sarcoma, Kaposi / complications*
Sarcoma, Kaposi / virology
Senegal / ethnology
Skin Neoplasms / complications
Talc / administration & dosage
Tomography, X-Ray Computed
Treatment Outcome

Substances

Talc